JP2021519599A5 - - Google Patents

Info

Publication number
JP2021519599A5
JP2021519599A5 JP2020554527A JP2020554527A JP2021519599A5 JP 2021519599 A5 JP2021519599 A5 JP 2021519599A5 JP 2020554527 A JP2020554527 A JP 2020554527A JP 2020554527 A JP2020554527 A JP 2020554527A JP 2021519599 A5 JP2021519599 A5 JP 2021519599A5
Authority
JP
Japan
Prior art keywords
ospa
antigenic
polypeptide
serotype
antigenic ospa
Prior art date
Application number
JP2020554527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519599A (ja
JPWO2019195276A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025367 external-priority patent/WO2019195276A1/en
Publication of JP2021519599A publication Critical patent/JP2021519599A/ja
Publication of JP2021519599A5 publication Critical patent/JP2021519599A5/ja
Publication of JPWO2019195276A5 publication Critical patent/JPWO2019195276A5/ja
Priority to JP2024002941A priority Critical patent/JP2024038345A/ja
Pending legal-status Critical Current

Links

JP2020554527A 2018-04-03 2019-04-02 抗原性ospaポリペプチド Pending JP2021519599A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024002941A JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652210P 2018-04-03 2018-04-03
US62/652,210 2018-04-03
PCT/US2019/025367 WO2019195276A1 (en) 2018-04-03 2019-04-02 Antigenic ospa polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024002941A Division JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Publications (3)

Publication Number Publication Date
JP2021519599A JP2021519599A (ja) 2021-08-12
JP2021519599A5 true JP2021519599A5 (https=) 2022-04-07
JPWO2019195276A5 JPWO2019195276A5 (https=) 2022-04-07

Family

ID=66397424

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554527A Pending JP2021519599A (ja) 2018-04-03 2019-04-02 抗原性ospaポリペプチド
JP2024002941A Pending JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024002941A Pending JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Country Status (7)

Country Link
US (2) US11993636B2 (https=)
EP (1) EP3773697A1 (https=)
JP (2) JP2021519599A (https=)
KR (1) KR20210018205A (https=)
CN (1) CN112584858A (https=)
CA (1) CA3095174A1 (https=)
WO (1) WO2019195276A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167584B (zh) * 2016-11-07 2024-06-07 威斯塔解剖学和生物学研究所 用于针对莱姆病的dna抗体构建体
CN112512566A (zh) 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽
BR112020019938A2 (pt) 2018-04-03 2021-01-26 Sanofi polipeptídeos antigênicos de vírus sincicial respiratório
CN112512564A (zh) 2018-04-03 2021-03-16 赛诺菲 铁蛋白蛋白
CN111217918B (zh) * 2020-03-04 2020-11-10 中山大学 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗
CN111217919B (zh) * 2020-03-04 2020-12-01 中山大学 一种基于火球菌铁蛋白的新型冠状病毒s蛋白双区域亚单位纳米疫苗
WO2023044016A2 (en) * 2021-09-17 2023-03-23 Cspc Dophen Corporation Antibody immune-stimulant conjugates and use thereof
WO2023111262A1 (en) 2021-12-17 2023-06-22 Sanofi Lyme disease rna vaccine
WO2023214082A2 (en) 2022-05-06 2023-11-09 Sanofi Signal sequences for nucleic acid vaccines
CN114736293B (zh) * 2022-06-14 2022-09-02 中国农业科学院生物技术研究所 SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用
IL325800A (en) * 2023-07-10 2026-03-01 Dynavax Tech Corp Lyme disease vaccines containing adjuvant and Borrelia outer protein A antigen
WO2025015077A1 (en) * 2023-07-10 2025-01-16 Dynavax Technologies Corporation Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2057536C (en) * 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
ATE509102T1 (de) 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
AU7690898A (en) 1997-05-20 1998-12-11 Ottawa Civic Hospital Loeb Research Institute Vectors and methods for immunization or therapeutic protocols
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
WO2001075436A1 (en) 2000-04-03 2001-10-11 Board Of Trustees Of The Leland Stanford Junior University A method for protein structure alignment
WO2002016421A2 (en) * 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
EP1504037B1 (en) * 2002-05-10 2009-12-30 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
US7774185B2 (en) 2004-09-14 2010-08-10 International Business Machines Corporation Protein structure alignment using cellular automata
AU2008339984A1 (en) 2007-12-21 2009-07-02 Glaxosmithkline Biologicals S.A. Vaccine
WO2009126816A1 (en) * 2008-04-09 2009-10-15 Ventria Bioscience Production of ospa for lyme disease control
CZ301541B6 (cs) * 2008-06-25 2010-04-07 Biologické centrum AV CR, v.v.i., Parazitologický ústav Feritin 2 pro imunizaci organismu proti klíštatum
EP3705133B1 (en) * 2010-05-14 2024-06-26 Baxalta Incorporated Ospa chimeras and use thereof in vaccines
EP2694109A4 (en) 2011-04-07 2015-02-18 Neotope Biosciences Ltd COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROTEIN AGGREGATION DISEASES WITH IC3B DEPOSITION
EP2515112B1 (en) 2011-04-22 2015-08-12 Sysmex Corporation Method for electrochemically detecting analyte
JP5795184B2 (ja) 2011-04-22 2015-10-14 国立大学法人 奈良先端科学技術大学院大学 被検物質の電気化学的検出方法
AU2013295647B2 (en) 2012-07-26 2018-02-08 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Multimeric fusion protein vaccine and immunotherapeutic
CZ2014320A3 (cs) * 2014-05-09 2015-11-18 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
CA2950085A1 (en) * 2014-05-27 2015-12-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Stabilized influenza hemagglutinin stem region trimers and uses thereof
US9703095B2 (en) 2015-01-05 2017-07-11 Edward Pakhchyan Light modulator for MEMS display
WO2016138160A1 (en) * 2015-02-24 2016-09-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
KR20180088458A (ko) 2015-12-04 2018-08-03 다나-파버 캔서 인스티튜트 인크. 암의 치료를 위한 mica/b 알파 3 도메인의 백신접종
FI3471760T3 (fi) 2016-06-17 2025-01-27 Boehringer Ingelheim Vetmedica Gmbh Lineaarisia tai haaroittuneita polyakryylihappopolymeeriadjuvantteja käsittäviä uusia immunogeenisiä formulaatioita
UA129243C2 (uk) 2017-04-19 2025-02-26 Інстітьют Фо Рісьорч Ін Біомедцін Антитіло, що зв'язується зі спорозоїтами p. falciparum
EP3713601A4 (en) 2017-11-21 2022-03-09 Modernatx, Inc. VACCINES AGAINST EPSTEIN-BARR VIRUS

Similar Documents

Publication Publication Date Title
JP2021519599A5 (https=)
US20240067681A1 (en) Subunit vaccine for treatment or prevention of a respiratory tract infection
JP2021519597A5 (https=)
JP2010162023A5 (https=)
JP2023162283A5 (https=)
JP2008529558A5 (https=)
JP2009544333A5 (https=)
JP2008530245A5 (https=)
JP2013507907A5 (https=)
JP2006512300A5 (https=)
JP2010500399A5 (https=)
JP2014530010A5 (https=)
JP2014507146A5 (https=)
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
JP2014503172A5 (https=)
JPWO2019195276A5 (https=)
HRP20170094T1 (hr) Imunogeni pripravak
JP2009515831A5 (https=)
JP2016514713A5 (https=)
JP2015509707A5 (https=)
JP2016504993A5 (https=)
HRP20130022T1 (hr) Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora
JP2012516140A5 (https=)
JP2021506824A5 (https=)
JP2012506699A5 (https=)